These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2444779)

  • 1. Acute hemodynamic and neurohumoral effects of pindolol: a beta-adrenoceptor antagonist with high intrinsic sympathomimetic activity in patients with dilated cardiomyopathy.
    Majid PA; Niznick J; Nishizaki S; Morris WM; Sole MJ
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):309-14. PubMed ID: 2444779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
    Majid PA; Morris WM; Sole MJ
    Can J Cardiol; 1987 Mar; 3(2):70-4. PubMed ID: 3567710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
    Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
    J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
    Amende I; Simon R; Hood WP; Lichtlen PR
    Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamics, plasma catecholamine behavior and beta-adrenergic receptor density in trained and untrained subjects and cardiac insufficiency patients].
    Lehmann M; Rühle K; Schmid P; Klein H; Matthys K; Keul J
    Z Kardiol; 1983 Sep; 72(9):529-36. PubMed ID: 6314688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
    Watanabe K; Hirokawa Y; Shibata A
    J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure.
    Cozzolino D; Sasso FC; Salvatore T; Torella M; Gentile S; Torella R; Giugliano D
    Am Heart J; 2004 Sep; 148(3):E13. PubMed ID: 15389249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy.
    Binkley PF; Lewe RF; Lima JJ; Al-Awwa A; Unverferth DV; Leier CV
    Circulation; 1986 Dec; 74(6):1390-8. PubMed ID: 3536153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity.
    Shanes JG; Wolfkiel C; Ghali J; Dierenfeldt BJ; Kondos GT; Bauman JL
    Am Heart J; 1988 Nov; 116(5 Pt 1):1268-75. PubMed ID: 3189143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability in dilated cardiomyopathy.
    Biswas PK; Basu S; Mitra KK; Chowdhury SP; Chatterjee BP; Das Biswas A; Chatterjee SS; Maity AK
    Indian Heart J; 2000; 52(2):187-91. PubMed ID: 10893896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The improvement in physical exercise capacity in dilated cardiomyopathy during short-term treatment with L-thyroxine].
    Doria E; Agostoni PG; Capacchione V; Sganzerla P; Moruzzi P
    Cardiologia; 1992 Jan; 37(1):31-4. PubMed ID: 1581920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.